- Trials with a EudraCT protocol (3,055)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (17,677)
3,055 result(s) found for: H.
Displaying page 1 of 153.
EudraCT Number: 2012-000299-40 | Sponsor Protocol Number: CRAD001C2121 | Start Date*: 2016-05-12 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A randomized, open label, two-way crossover study investigating the relative bioavailability of a single 5 mg dose of everolimus administered as either 5x1 mg everolimus intact tablets or 5x1 mg ev... | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2016-002119-16 | Sponsor Protocol Number: NORM2016-IQ | Start Date*: 2016-11-10 | |||||||||||
Sponsor Name:Aflofarm Farmacja Polska Sp. z o.o. | |||||||||||||
Full Title: Multi-center phase 3 clinical study of fever reduction effectiveness in children age 24-72 months using combined therapy (ibuprofen plus paracetamol) compared to monotherapy with paracetamol and/or... | |||||||||||||
Medical condition: Fever due to viral infection | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004928-15 | Sponsor Protocol Number: CA056-015 | Start Date*: 2022-09-28 | |||||||||||
Sponsor Name:Celgene Corporation | |||||||||||||
Full Title: A Phase 2, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of Luspatercept (BMS-986346/ACE-536) for the Treatment of Anemia in Adults with Alpha... | |||||||||||||
Medical condition: Alpha (α)-thalassemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001265-17 | Sponsor Protocol Number: 3.0 | Start Date*: 2018-08-07 |
Sponsor Name:Turku University Central Hospital | ||
Full Title: Relationship of edoxaban plasma concentration and blood coagulation in healthy volunteers using standard laboratory tests and viscoelastic analysis (EdoRot). | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-024249-59 | Sponsor Protocol Number: ULA01 | Start Date*: 2012-10-18 |
Sponsor Name:Cardiorentis Ltd. | ||
Full Title: Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ularitide (Urodilatin) Intravenous Infusion in Patients Suffering from Acute Decomp... | ||
Medical condition: Acute Decompensated Heart Failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) DE (Prematurely Ended) HU (Prematurely Ended) NL (Prematurely Ended) FI (Prematurely Ended) IT (Completed) LT (Prematurely Ended) EE (Prematurely Ended) LV (Prematurely Ended) ES (Prematurely Ended) PL (Prematurely Ended) SE (Ongoing) BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000248-32 | Sponsor Protocol Number: CICL670F2102 | Start Date*: 2016-03-15 |
Sponsor Name:Novartis Pharmaceuticals Corporation | ||
Full Title: A randomized, open-label, single center, phase I, cross-over study to evaluate the pharmacokinetic comparability of deferasirox new tablet formulation with the reference dispersible formulation in ... | ||
Medical condition: Healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2018-003945-40 | Sponsor Protocol Number: EPU-P112 | Start Date*: 2019-04-10 |
Sponsor Name:Maastricht University | ||
Full Title: EFFECTS OF VAPORISED CANNABIS, WITH AND WITHOUT CBD, ON DRIVING AND COGNITION | ||
Medical condition: This study will look at the differential effects of variations in cannabis chemovars on driving ability and cognition | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000182-31 | Sponsor Protocol Number: CHDR1438 | Start Date*: 2015-02-11 |
Sponsor Name:CHDR | ||
Full Title: A randomized, double-blind, placebo-controlled, cross-over study to assess the effects of fampridine on eye movements and nerve conduction in patients with multiple sclerosis (MS) and a unilateral ... | ||
Medical condition: Multiple sclerosis (MS) and a unilateral or bilateral internuclear ophthalmoplegia (INO) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003652-20 | Sponsor Protocol Number: Ptcl-01501 | Start Date*: 2013-12-04 | |||||||||||
Sponsor Name:D-Pharm Ltd. | |||||||||||||
Full Title: Pilot trial of intravenous DP-b99 in the treatment of first-ever episode of non-obstructive acute high-risk pancreatitis | |||||||||||||
Medical condition: Acute pancreatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) SK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011865-10 | Sponsor Protocol Number: FINA-004 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:MerLion Pharmaceuticals GmbH | |||||||||||||
Full Title: An Open-label, Randomised, Multicentre, Multi-country Three-arm Study of the Treatment with Finafloxacin 400 mg b.i.d. plus Esomeprazole 40 mg b.i.d. for 14 days versus Finafloxacin 400 mg b.i.d. p... | |||||||||||||
Medical condition: Helicobacter pylori infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) LT (Prematurely Ended) LV (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001080-23 | Sponsor Protocol Number: R+OCA | Start Date*: 2014-05-26 | |||||||||||
Sponsor Name:Javier P. Gisbert | |||||||||||||
Full Title: Rifaximin associated with the classic triple therapy (inhibitor proton pump, amoxicillin and clarithromycin) for eradication of Helicobacter pylori infection | |||||||||||||
Medical condition: Helicobacter pylori infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001598-33 | Sponsor Protocol Number: PSC-DS-BRETEX | Start Date*: 2016-07-27 | |||||||||||
Sponsor Name:SOFAR S.P.A. | |||||||||||||
Full Title: Comparison of two methods for in vivo diagnosis of Helicobacter pylori infection, by means of a tablet of 13C-Urea. | |||||||||||||
Medical condition: H. pylori infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007749-11 | Sponsor Protocol Number: FINA-002 | Start Date*: 2008-08-05 | |||||||||||
Sponsor Name:MerLion Pharmaceuticals GmbH | |||||||||||||
Full Title: An open-label, randomized, multicenter, two-arm efficacy and safety study of 14 days treatment with Finafloxacin 400 mg b.i.d. plus Amoxicillin 1000 mg b.i.d. versus Finafloxacin 400 mg b.i.d. plus... | |||||||||||||
Medical condition: Helicobacter pylori infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005617-39 | Sponsor Protocol Number: WS2030571 | Start Date*: 2014-01-14 |
Sponsor Name:University Hospital Tuebingen | ||
Full Title: Pharmacokinetics of Tigecycline in Patients Receiving Continuous Renal Replacement Therapy | ||
Medical condition: Surgical ICU patients with severe infection and renal replacement therapy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004614-18 | Sponsor Protocol Number: BPR-PIP-001 | Start Date*: 2014-07-30 | ||||||||||||||||
Sponsor Name:Basilea Pharmaceutica International Ltd. | ||||||||||||||||||
Full Title: An Open-Label Study to Evaluate the Single-Dose Pharmacokinetics and Safety of Ceftobiprole in Neonate and Infant Subjects Aged ≤ 3 Months Undergoing Treatment with Systemic Antibiotics | ||||||||||||||||||
Medical condition: documented or presumed bacterial infections, or at risk of a bacterial infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Prematurely Ended) DE (Prematurely Ended) LT (Prematurely Ended) PL (Prematurely Ended) LV (Prematurely Ended) Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002898-35 | Sponsor Protocol Number: CA209-848 | Start Date*: 2018-12-21 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden... | |||||||||||||
Medical condition: Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) FR (Completed) DK (Completed) GB (GB - no longer in EU/EEA) ES (Ongoing) NL (Completed) PL (Completed) BE (Completed) Outside EU/EEA IT (Completed) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000342-22 | Sponsor Protocol Number: VALACT-2017-01 | Start Date*: 2017-04-04 | |||||||||||
Sponsor Name:Dr. Luis Fernández-Dr. Jesus Barrio | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled study of the usefulness of the probiotic 'Lactobacillus reuteri' in the therapy of quadruple eradication of Helicobacter pylori infection in usual cli... | |||||||||||||
Medical condition: Helicobacter Pylori infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005914-18 | Sponsor Protocol Number: APIDR_L_00465 | Start Date*: 2006-03-15 |
Sponsor Name:Diabetes-Centre Quakenbrueck | ||
Full Title: Effect of Insulin Glulisin on postprandial plasma glucose levels in obese subjectts with type 2 diabetes after a standard meal in comparison to Insulin Lispro | ||
Medical condition: Obese subjects with type 2 diabetes mellitus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002875-34 | Sponsor Protocol Number: CL-070-II-02 | Start Date*: Information not available in EudraCT |
Sponsor Name:IDEA AG | ||
Full Title: Safety and efficacy of IDEA-070 for the treatment of pain and inflammation induced by photodynamic therapy of actinic keratosis | ||
Medical condition: Patients suffering from actinic keratosis to be treated with PDT | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002854-22 | Sponsor Protocol Number: UGA2014-01 | Start Date*: 2020-01-03 | ||||||||||||||||
Sponsor Name:Aryogen Pharmed | ||||||||||||||||||
Full Title: A RANDOMIZED, MULTICENTER, DOUBLE BLIND CLINICAL TRIAL COMPARING PHARMACODYNAMIC, PHARMACOKINETIC AND SAFETY OF A BIOSIMILAR EPTACOG ALFA (ARYOSEVEN) AND NOVOSEVEN®, IN PATIENTS WITH HAEMOPHILIA A ... | ||||||||||||||||||
Medical condition: HAEMOPHILIA A OR B WITH INHIBITORS | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: BG (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
